Clinical trial
Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
NCT00006204 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00006204 |
|---|---|
| Title | Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine) |
| Official title | Combined Pharmacotherapy in Depressed Alcoholics |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism, Alcohol Dependence, Depression |
| Intervention type | Drug |
| Interventions | naltrexone (Revia), fluoxetine (Prozac) |
| Enrollment | 106 |
| Start date | Mar 1, 2000 |
| Completion | Jan 1, 2006 |
| First posted | Sep 12, 2000 |
| Last update posted | Dec 10, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: